Showing results (191-200 of 219) with videos related to
Sort By:
Pageof 22
Frontiers in Cardiovascular Medicine|January 23, 2023
Potential value of saline-induced Pd/Pa ratio in patients with coronary artery stenosisHiroyuki Kiriyama, Arihiro Kiyosue, Shun Minatsuki, et al.Scientific Reports|December 4, 2020
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancerRyota Takahashi, Hideaki Ijichi, Makoto Sano, et al.Journal of Gastroenterology|February 4, 2010
Bezafibrate for the treatment of primary sclerosing cholangitisSuguru Mizuno, Kenji Hirano, Minoru Tada, et al.Cancer Chemotherapy and Pharmacology|June 22, 2010
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapyTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.Journal of Gastroenterology and Hepatology|March 18, 2014
Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstructionYousuke Nakai, Hiroyuki Isayama, Kazumichi Kawakubo, et al.Oncology|June 17, 2011
Gemcitabine and oxaliplatin combination chemotherapy for patients with refractory pancreatic cancerHiroyuki Isayama, Yousuke Nakai, Keisuke Yamamoto, et al.Journal of Gastroenterology|June 28, 2012
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.Oncotarget|August 17, 2016
Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancerKeisuke Yamamoto, Keisuke Tateishi, Yotaro Kudo, et al.Anticancer Research|September 16, 2016
No Survival Benefit from the Inhibition of Renin-Angiotensin System in Biliary Tract CancerYousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, et al.Oncology|November 20, 2009
A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancerYousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, et al.Pageof 22